» Articles » PMID: 30833328

Proximal Tubule Transferrin Uptake is Modulated by Cellular Iron and Mediated by Apical Membrane Megalin-cubilin Complex and Transferrin Receptor 1

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2019 Mar 6
PMID 30833328
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Receptor-mediated endocytosis is responsible for reabsorption of transferrin (Tf) in renal proximal tubules (PTs). Although the role of the megalin-cubilin receptor complex (MCRC) in this process is unequivocal, modalities independent of this complex are evident but as yet undefined. Here, using immunostaining and Tf-flux assays, FACS analysis, and fluorescence imaging, we report localization of Tf receptor 1 (TfR1), the cognate Tf receptor mediating cellular holo-Tf (hTf) acquisition, to the apical brush border of the PT, with expression gradually declining along the PT in mouse and rat kidneys. In functional studies, hTf uptake across the apical membrane of cultured PT epithelial cell (PTEC) monolayers increased in response to decreased cellular iron after desferrioxamine (DFO) treatment. We also found that apical hTf uptake under basal conditions is receptor-associated protein (RAP)-sensitive and therefore mediated by the MCRC but becomes RAP-insensitive under DFO treatment, with concomitantly decreased megalin and cubilin expression levels and increased TfR1 expression. Thus, as well as the MCRC, TfR1 mediates hTf uptake across the PT apical brush border, but in conditions of decreased cellular iron, hTf uptake is predominated by augmented apical TfR1. In conclusion, both the MCRC and TfR1 mediate hTf uptake across apical brush border membranes of PTECs and reciprocally respond to decreased cellular iron. Our findings have implications for renal health, whole-body iron homeostasis, and pathologies arising from disrupted iron balance.

Citing Articles

Antioxidative Function of Zinc and Its Protection Against the Onset and Progression of Kidney Disease Due to Cadmium.

Satarug S Biomolecules. 2025; 15(2).

PMID: 40001486 PMC: 11853145. DOI: 10.3390/biom15020183.


Iron-Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus.

Huang B, Wen W, Ye S J Diabetes. 2025; 17(2):e70060.

PMID: 39968673 PMC: 11836615. DOI: 10.1111/1753-0407.70060.


Machine learning and 4D-LFQ quantitative proteomic analysis explore the molecular mechanism of kidney stone formation.

He Z, Zhou J, Dong C, Song C, Liao W, Xiong Y Heliyon. 2024; 10(14):e34405.

PMID: 39114033 PMC: 11305192. DOI: 10.1016/j.heliyon.2024.e34405.


Advance in Iron Metabolism, Oxidative Stress and Cellular Dysfunction in Experimental and Human Kidney Diseases.

Xie T, Yao L, Li X Antioxidants (Basel). 2024; 13(6).

PMID: 38929098 PMC: 11200795. DOI: 10.3390/antiox13060659.


Integrating tumor and healthy epithelium in a micro-physiology multi-compartment approach to study renal cell carcinoma pathophysiology.

Somova M, Simm S, Padmyastuti A, Ehrhardt J, Schoon J, Wolff I Sci Rep. 2024; 14(1):9357.

PMID: 38653823 PMC: 11039668. DOI: 10.1038/s41598-024-60164-w.


References
1.
Ferguson C, Wareing M, Ward D, Green R, Smith C, Riccardi D . Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am J Physiol Renal Physiol. 2001; 280(5):F803-14. DOI: 10.1152/ajprenal.2001.280.5.F803. View

2.
Betten R, Scharner B, Probst S, Edemir B, Wolff N, Langelueddecke C . Tonicity inversely modulates lipocalin-2 (Lcn2/24p3/NGAL) receptor (SLC22A17) and Lcn2 expression via Wnt/β-catenin signaling in renal inner medullary collecting duct cells: implications for cell fate and bacterial infection. Cell Commun Signal. 2018; 16(1):74. PMC: 6223074. DOI: 10.1186/s12964-018-0285-3. View

3.
Smith C, Thevenod F . Iron transport and the kidney. Biochim Biophys Acta. 2008; 1790(7):724-30. DOI: 10.1016/j.bbagen.2008.10.010. View

4.
Lu J, Hayashi K, AWAI M . Transferrin receptor expression in normal, iron-deficient and iron-overloaded rats. Acta Pathol Jpn. 1989; 39(12):759-64. DOI: 10.1111/j.1440-1827.1989.tb02427.x. View

5.
Breuer W, Ronson A, Slotki I, Abramov A, Hershko C, Cabantchik Z . The assessment of serum nontransferrin-bound iron in chelation therapy and iron supplementation. Blood. 2000; 95(9):2975-82. View